Drug Shortage Report for YAZ PLUS
| Report ID | 49534 |
| Drug Identification Number | 02387433 |
| Brand name | YAZ PLUS |
| Common or Proper name | drospirenone/ethinyl estradiol/levomefolate calcium tablets and levomefolate calcium tablets |
| Company Name | BAYER INC |
| Market Status | MARKETED |
| Active Ingredient(s) | DROSPIRENONE Levomefolate Calcium ETHINYL ESTRADIOL |
| Strength(s) | 3.00MG 0.451MG 0.02MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 28's |
| ATC code | G03AA |
| ATC description | HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2018-05-25 |
| Actual start date | |
| Estimated end date | 2018-09-25 |
| Actual end date | 2018-09-12 |
| Shortage status | Resolved |
| Updated date | 2018-09-13 |
| Company comments | Product available in the market. |
| Health Canada comments | |
| Contact Address | 2920 MATHESON BLVD EAST MISSISSAUGA, ONTARIO CANADA L4W 5R6 |
| Company contact information | 1-800-265-7382 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.